J.P. MORGAN

July 24, 2020February 26, 2019 by Abel Rodriguez

January 2019:

ARTHEx S.L. participation at the 37th Annual J.P. Morgan Healthcare Conference, celebrated from January 7 to 10 2019 in San Francisco, California.

Retweet on Twitter ARTHEx biotech Retweeted

<img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" alt="Arthexbiotech" width="48" height="48">

ARTHEx biotech @Arthexbiotech·

We are proud to see how our team is gaining experience advancing towards a therapy against Myotonic Dystrophy disease. #Arthex welcomes Dr. Nicholas Johnson as our MRW Chief Medical Advisor

<img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" alt="Arthexbiotech" width="48" height="48">

ARTHEx biotech @Arthexbiotech·

We are proud to see how our team is gaining experience advancing towards a therapy against Myotonic Dystrophy disease. #Arthex welcomes Dr. Nicholas Johnson as our MRW Chief Medical Advisor

<img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" alt="Arthexbiotech" width="48" height="48">

ARTHEx biotech @Arthexbiotech·

Thanks to the investors for their support that will push us into clinical studies

Retweet on Twitter ARTHEx biotech Retweeted

Invivo Capital @InvivoCapital·

Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology
https://invivo.capital/#noticias

<img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img alt="Arthexbiotech" width="48" height="48" data-src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://pbs.twimg.com/profile_images/1096054456775593985/i67lubtj_normal.jpg" alt="Arthexbiotech" width="48" height="48">

ARTHEx biotech @Arthexbiotech·

We are excited about our new funding round! Thanks @AdventFrance and @InvivoCapital for your support and confidence. Working together for a new RNA therapy for myotonic dystrophy type I!. Welcome Alain Huriez to our Board of Directors.